K. ÖZKAYA TORAMAN Et Al. , "Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort," Journal of Chemotherapy , vol.36, no.2, pp.133-142, 2024
ÖZKAYA TORAMAN, K. Et Al. 2024. Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort. Journal of Chemotherapy , vol.36, no.2 , 133-142.
ÖZKAYA TORAMAN, K., MERAL, R., Karadeniz, A. N., Kaval, G., BAŞARAN, M., EKENEL, M., ... ALTUN, M.(2024). Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort. Journal of Chemotherapy , vol.36, no.2, 133-142.
ÖZKAYA TORAMAN, Kübra Et Al. "Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort," Journal of Chemotherapy , vol.36, no.2, 133-142, 2024
ÖZKAYA TORAMAN, Kübra Ö. Et Al. "Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort." Journal of Chemotherapy , vol.36, no.2, pp.133-142, 2024
ÖZKAYA TORAMAN, K. Et Al. (2024) . "Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort." Journal of Chemotherapy , vol.36, no.2, pp.133-142.
@article{article, author={Kübra ÖZKAYA TORAMAN Et Al. }, title={Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort}, journal={Journal of Chemotherapy}, year=2024, pages={133-142} }